Koss-Olinger Consulting, LLC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 162 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
Koss-Olinger Consulting, LLC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$238,000
-40.6%
9,300
-33.5%
0.04%
-25.5%
Q2 2023$401,000
+19.7%
13,9750.0%0.05%
+11.9%
Q1 2023$335,000
-84.0%
13,975
-68.1%
0.04%
-87.7%
Q3 2021$2,093,000
+5.2%
43,800
-25.5%
0.34%
+15.6%
Q2 2021$1,990,000
+140.9%
58,800
+194.0%
0.30%
+109.2%
Q1 2021$826,00020,0000.14%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2021
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 456,390$5,541,0003.62%
DAFNA Capital Management LLC 173,914$1,890,0000.65%
One68 Global Capital, LLC 19,861$216,0000.47%
Diametric Capital, LP 51,982$565,0000.41%
ARK Investment Management 1,383,756$15,041,0000.38%
EAM Investors, LLC 52,833$574,0000.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 31,404$341,0000.05%
Nikko Asset Management Americas, Inc. 280,548$3,050,0000.05%
MGO ONE SEVEN LLC 14,900$161,0000.04%
Qube Research & Technologies Ltd 67,702$736,0000.02%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders